1. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
   Luca Bedon et al, 2021, International Journal of Molecular Sciences CrossRef
2. Diagnostic value of FOXF1 gene promoter-methylated DNA in the plasma samples of patients with colorectal cancer
   Zahra Dastafkan et al, 2023, The International Journal of Biological Markers CrossRef
3. Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese
   Jie Zhong et al, 2019, Pathology - Research and Practice CrossRef
4. Nucleic acid aptamers in diagnosis of colorectal cancer
   Yaghoub Ahmadyousefi et al, 2019, Biochimie CrossRef
5. DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples
   Eivor Alette Laugsand et al, 2021, International Journal of Colorectal Disease CrossRef
6. A Comparison of MGMT Testing by MSP and qMSP in Paired Snap-Frozen and Formalin-Fixed Paraffin-Embedded Gliomas
   Milica Lazarević et al, 2023, Diagnostics CrossRef
7. The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
   Nikola Jovanović et al, 2019, Medicina CrossRef
8. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
   Vera Constâncio et al, 2020, Cells CrossRef
9. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview
   Iman Akhlaghipour et al, 2021, Genes and Environment CrossRef
10. A systematic review and meta-analysis of the DNA methylation in colorectal cancer among Iranian population
    Soraya Bilvayeh et al, 2021, Gene Reports CrossRef
11. Circulating biomarkers for early detection and clinical management of colorectal cancer
    María Marcuello et al, 2019, Molecular Aspects of Medicine CrossRef
12. Computer-aided biomarker discovery for precision medicine: data resources, models and applications
    Yuxin Lin et al, 2019, Briefings in Bioinformatics CrossRef
13. Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese
    Ranran Pan et al, 2018, Experimental and Therapeutic Medicine CrossRef
14. A novel epigenetic biomarker, plasma miR-138-5p gene promoter-methylated DNA, for colorectal cancer diagnosis
    Masoud Asefi et al, 2022, Personalized Medicine CrossRef
15. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis
    Liang Min et al, 2023, Journal of Clinical Medicine CrossRef
16. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers
    Chi Chun Wong et al, 2019, Seminars in Cancer Biology CrossRef
17. DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine
    Jingxin Ye et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
18. Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules
    Shiqi Zhang et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef
19. Racial Disparities in Methylation of NRF1, FTO, and LEPR Gene in Childhood Obesity
    Priyadarshni Patel et al, 2022, Genes CrossRef
20. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells
    Raffaele Frazzi et al, 2021, Oncology Reports CrossRef
21. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer
    Maryam Alizadeh-Sedigh et al, 2022, Cancer Biomarkers CrossRef